Amphastar Pharmaceuticals (AMPH) Financial Statements & Analysis

Amphastar Pharmaceuticals (AMPH) Income Statement

Amphastar Pharmaceuticals reported revenue of $719.89M in fiscal 2025 (fiscal year ended Dec 31, 2025), down 1.7% from $731.97M a year earlier. Net income was $98.09M, down 38.5% year over year, a net margin of 13.6%. Gross margin was 49.5% and operating margin 19.5%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $183.90M, up 5.4% from the same quarter a year earlier.

Amphastar Pharmaceuticals Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Amphastar Pharmaceuticals, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	719.89	731.97	644.40	498.99	437.77	349.85	322.36	294.67	240.18
Cost of Revenue	363.83	358.11	293.27	250.13	238.03	206.51	190.43	187.68	149.38
Gross Profit	356.06	373.86	351.12	248.86	199.74	143.34	131.92	106.99	90.80
Operating Expenses
Research & Development	85.84	73.91	73.74	74.77	60.93	67.23	68.85	57.56	43.42
Selling, General & Administrative	129.81	94.52	80.39	66.59	68.92	65.16	63.11	58.04	50.92
Operating Expenses	215.65	168.44	154.13	141.36	129.85	132.39	131.96	115.61	94.33
Operating Income	140.40	205.42	196.99	107.50	69.89	10.95	-0.04	-8.62	-0.90
Other Income/Expense
Interest Income	8.68	10.61	5.46	1.32	0.60	0.64	1.00	0.46	0.43
Interest Expense	25.48	30.34	27.16	1.85	0.89	0.37	0.12	0.24	0.83
Other Income/Expense	0.02	4.08	-27.61	9.07	14.54	-6.32	60.27	-1.30	2.52
Income
Income Before Tax	123.62	189.76	169.38	116.04	84.14	4.64	60.23	-9.93	1.62
Income Tax Expense	25.53	29.67	31.83	23.48	20.63	3.54	13.72	-3.27	-2.89
Net Income	98.09	159.52	137.55	91.39	62.12	1.40	48.94	-5.74	4.51
Net Income - Continuous Operations	98.09	159.52	137.55	91.39	63.30	1.40	48.94	-5.74	4.51
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	212.31	277.31	240.29	146.16	111.56	30.19	81.47	6.83	11.90
EBIT	149.11	220.11	198.52	117.89	85.02	13.25	-	-	-
Depreciation & Amortization	63.20	57.21	41.78	28.28	26.53	25.18	21.12	16.52	15.81
Earnings Per Share
Basic EPS	2.00	3.00	3.00	2.00	1.00	-	1.00	-	-
Diluted EPS	2.00	3.00	3.00	2.00	1.00	-	1.00	-	-
Basic Shares Outstanding	46.74	48.43	48.27	48.55	47.78	47.04	46.98	46.40	46.11
Diluted Shares Outstanding	48.22	52.06	53.00	52.43	49.78	49.12	49.91	46.40	48.37

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Amphastar Pharmaceuticals Financial Statements

What was Amphastar Pharmaceuticals's revenue in fiscal 2025?

Amphastar Pharmaceuticals reported revenue of $719.89M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 1.7% from $731.97M a year earlier.

Is Amphastar Pharmaceuticals profitable?

Yes. Amphastar Pharmaceuticals earned net income of $98.09M in fiscal 2025, a net margin of 13.6%. In fiscal 2024 it earned $159.52M.

What is Amphastar Pharmaceuticals's operating margin?

Amphastar Pharmaceuticals's operating income was $140.40M on revenue of $719.89M in fiscal 2025, an operating margin of 19.5%, compared with 28.1% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition